Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes - PubMed
Most patients initiate second-line therapy at elevated HbA<sub>1c</sub> levels, with highly heterogeneous clinical characteristics across ADD classes. Despite the introduction of newer therapies, sulfonylureas remained the most popular second-line agent, and the rates of intensification with sulfony …
pubmed.ncbi.nlm.nih.gov